Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
Identifieur interne : 000090 ( Main/Exploration ); précédent : 000089; suivant : 000091Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
Auteurs : Barbara Michiels [Belgique] ; Hilde Philips ; Samuel Coenen ; Joke Denekens ; Paul Van RoyenSource :
- Vaccine [ 0264-410X ] ; 2006.
Descripteurs français
- KwdFr :
- Anticorps antiviraux (sang), Belgique, Femelle, Grippe humaine (), Humains, Mâle, Médecins de famille, Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H3N2 du virus de la grippe A (immunologie), Statistiques comme sujet, Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (immunologie), Virus influenza B (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- immunologie : Sous-type H1N1 du virus de la grippe A, Sous-type H3N2 du virus de la grippe A, Vaccins antigrippaux, Virus influenza B.
- sang : Anticorps antiviraux.
- Belgique, Femelle, Grippe humaine, Humains, Mâle, Médecins de famille, Statistiques comme sujet.
- Wicri :
- geographic : Belgique.
English descriptors
- KwdEn :
- Antibodies, Viral (blood), Belgium, Female, Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H3N2 Subtype (immunology), Influenza B virus (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (prevention & control), Male, Physicians, Family, Statistics as Topic.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Influenza Vaccines.
- geographic : Belgium.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza B virus.
- prevention & control : Influenza, Human.
- Female, Humans, Male, Physicians, Family, Statistics as Topic.
Abstract
Efficacy studies have not answered the question whether influenza vaccination among general practitioners (GPs) has a substantial additive effect on their immunity. To evaluate this effect the influenza antibody titres in vaccinated and unvaccinated GPs were compared in a controlled trial during two consecutive winter periods (2002-2003 and 2003-2004). The seroprotection rates against the circulating A/H3N2 influenza virus amount to 80% and 42% in the unvaccinated group in 2002 and 2003, respectively. In the vaccinated GPs the seroprotection rate increases from 91% to 96% in 2002 and from 70% to 83% in 2003 after vaccination. Besides vaccination, the (high) basic antibody titre before vaccination and working in a child and family preventive medicine unit were predicting a protective antibody level in GPs.
DOI: 10.1016/j.vaccine.2006.01.040
PubMed: 16490288
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).</title><author><name sortKey="Michiels, Barbara" sort="Michiels, Barbara" uniqKey="Michiels B" first="Barbara" last="Michiels">Barbara Michiels</name><affiliation wicri:level="1"><nlm:affiliation>Centre for General Practice, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk-Antwerpen, Belgium. barbara.michiels@pandora.be</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for General Practice, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk-Antwerpen</wicri:regionArea><wicri:noRegion>2610 Wilrijk-Antwerpen</wicri:noRegion></affiliation></author><author><name sortKey="Philips, Hilde" sort="Philips, Hilde" uniqKey="Philips H" first="Hilde" last="Philips">Hilde Philips</name></author><author><name sortKey="Coenen, Samuel" sort="Coenen, Samuel" uniqKey="Coenen S" first="Samuel" last="Coenen">Samuel Coenen</name></author><author><name sortKey="Denekens, Joke" sort="Denekens, Joke" uniqKey="Denekens J" first="Joke" last="Denekens">Joke Denekens</name></author><author><name sortKey="Van Royen, Paul" sort="Van Royen, Paul" uniqKey="Van Royen P" first="Paul" last="Van Royen">Paul Van Royen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16490288</idno><idno type="pmid">16490288</idno><idno type="doi">10.1016/j.vaccine.2006.01.040</idno><idno type="wicri:Area/Main/Corpus">000097</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000097</idno><idno type="wicri:Area/Main/Curation">000097</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000097</idno><idno type="wicri:Area/Main/Exploration">000097</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).</title><author><name sortKey="Michiels, Barbara" sort="Michiels, Barbara" uniqKey="Michiels B" first="Barbara" last="Michiels">Barbara Michiels</name><affiliation wicri:level="1"><nlm:affiliation>Centre for General Practice, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk-Antwerpen, Belgium. barbara.michiels@pandora.be</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Centre for General Practice, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk-Antwerpen</wicri:regionArea><wicri:noRegion>2610 Wilrijk-Antwerpen</wicri:noRegion></affiliation></author><author><name sortKey="Philips, Hilde" sort="Philips, Hilde" uniqKey="Philips H" first="Hilde" last="Philips">Hilde Philips</name></author><author><name sortKey="Coenen, Samuel" sort="Coenen, Samuel" uniqKey="Coenen S" first="Samuel" last="Coenen">Samuel Coenen</name></author><author><name sortKey="Denekens, Joke" sort="Denekens, Joke" uniqKey="Denekens J" first="Joke" last="Denekens">Joke Denekens</name></author><author><name sortKey="Van Royen, Paul" sort="Van Royen, Paul" uniqKey="Van Royen P" first="Paul" last="Van Royen">Paul Van Royen</name></author></analytic><series><title level="j">Vaccine</title><idno type="ISSN">0264-410X</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (blood)</term><term>Belgium</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza A Virus, H3N2 Subtype (immunology)</term><term>Influenza B virus (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Physicians, Family</term><term>Statistics as Topic</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (sang)</term><term>Belgique</term><term>Femelle</term><term>Grippe humaine ()</term><term>Humains</term><term>Mâle</term><term>Médecins de famille</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Sous-type H3N2 du virus de la grippe A (immunologie)</term><term>Statistiques comme sujet</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (immunologie)</term><term>Virus influenza B (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Belgium</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term><term>Sous-type H3N2 du virus de la grippe A</term><term>Vaccins antigrippaux</term><term>Virus influenza B</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza A Virus, H3N2 Subtype</term><term>Influenza B virus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Physicians, Family</term><term>Statistics as Topic</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Belgique</term><term>Femelle</term><term>Grippe humaine</term><term>Humains</term><term>Mâle</term><term>Médecins de famille</term><term>Statistiques comme sujet</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Belgique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Efficacy studies have not answered the question whether influenza vaccination among general practitioners (GPs) has a substantial additive effect on their immunity. To evaluate this effect the influenza antibody titres in vaccinated and unvaccinated GPs were compared in a controlled trial during two consecutive winter periods (2002-2003 and 2003-2004). The seroprotection rates against the circulating A/H3N2 influenza virus amount to 80% and 42% in the unvaccinated group in 2002 and 2003, respectively. In the vaccinated GPs the seroprotection rate increases from 91% to 96% in 2002 and from 70% to 83% in 2003 after vaccination. Besides vaccination, the (high) basic antibody titre before vaccination and working in a child and family preventive medicine unit were predicting a protective antibody level in GPs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16490288</PMID><DateCompleted><Year>2006</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0264-410X</ISSN><JournalIssue CitedMedium="Print"><Volume>24</Volume><Issue>16</Issue><PubDate><Year>2006</Year><Month>Apr</Month><Day>12</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).</ArticleTitle><Pagination><MedlinePgn>3145-52</MedlinePgn></Pagination><Abstract><AbstractText>Efficacy studies have not answered the question whether influenza vaccination among general practitioners (GPs) has a substantial additive effect on their immunity. To evaluate this effect the influenza antibody titres in vaccinated and unvaccinated GPs were compared in a controlled trial during two consecutive winter periods (2002-2003 and 2003-2004). The seroprotection rates against the circulating A/H3N2 influenza virus amount to 80% and 42% in the unvaccinated group in 2002 and 2003, respectively. In the vaccinated GPs the seroprotection rate increases from 91% to 96% in 2002 and from 70% to 83% in 2003 after vaccination. Besides vaccination, the (high) basic antibody titre before vaccination and working in a child and family preventive medicine unit were predicting a protective antibody level in GPs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Michiels</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for General Practice, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, 2610 Wilrijk-Antwerpen, Belgium. barbara.michiels@pandora.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philips</LastName><ForeName>Hilde</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Coenen</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Denekens</LastName><ForeName>Joke</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Van Royen</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010821" MajorTopicYN="Y">Physicians, Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2005</Year><Month>08</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2005</Year><Month>12</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>01</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>9</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>2</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16490288</ArticleId><ArticleId IdType="pii">S0264-410X(06)00068-5</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2006.01.040</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Belgique</li></country></list><tree><noCountry><name sortKey="Coenen, Samuel" sort="Coenen, Samuel" uniqKey="Coenen S" first="Samuel" last="Coenen">Samuel Coenen</name><name sortKey="Denekens, Joke" sort="Denekens, Joke" uniqKey="Denekens J" first="Joke" last="Denekens">Joke Denekens</name><name sortKey="Philips, Hilde" sort="Philips, Hilde" uniqKey="Philips H" first="Hilde" last="Philips">Hilde Philips</name><name sortKey="Van Royen, Paul" sort="Van Royen, Paul" uniqKey="Van Royen P" first="Paul" last="Van Royen">Paul Van Royen</name></noCountry><country name="Belgique"><noRegion><name sortKey="Michiels, Barbara" sort="Michiels, Barbara" uniqKey="Michiels B" first="Barbara" last="Michiels">Barbara Michiels</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeBelgiqueV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000090 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000090 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeBelgiqueV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:16490288
|texte= Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16490288" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeBelgiqueV4
| This area was generated with Dilib version V0.6.35. |  |